These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9520474)

  • 21. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
    Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH
    J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
    Schwenk R; DeBot M; Porter M; Nikki J; Rein L; Spaccapelo R; Crisanti A; Wightman PD; Ockenhouse CF; Dutta S
    PLoS One; 2014; 9(10):e111020. PubMed ID: 25343487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopes.
    Sedegah M; Hollingdale MR; Farooq F; Ganeshan H; Belmonte M; Kim Y; Peters B; Sette A; Huang J; McGrath S; Abot E; Limbach K; Shi M; Soisson L; Diggs C; Chuang I; Tamminga C; Epstein JE; Villasante E; Richie TL
    PLoS One; 2014; 9(9):e106241. PubMed ID: 25211344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
    Cummings JF; Spring MD; Schwenk RJ; Ockenhouse CF; Kester KE; Polhemus ME; Walsh DS; Yoon IK; Prosperi C; Juompan LY; Lanar DE; Krzych U; Hall BT; Ware LA; Stewart VA; Williams J; Dowler M; Nielsen RK; Hillier CJ; Giersing BK; Dubovsky F; Malkin E; Tucker K; Dubois MC; Cohen JD; Ballou WR; Heppner DG
    Vaccine; 2010 Jul; 28(31):5135-44. PubMed ID: 19737527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a nonameric H-2Kk-restricted CD8+ cytotoxic T lymphocyte epitope on the Plasmodium falciparum circumsporozoite protein.
    Malik A; Houghten R; Corradin G; Buus S; Berzofsky JA; Hoffman SL
    Infect Immun; 1995 May; 63(5):1955-9. PubMed ID: 7537251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma.
    Sun P; Schwenk R; White K; Stoute JA; Cohen J; Ballou WR; Voss G; Kester KE; Heppner DG; Krzych U
    J Immunol; 2003 Dec; 171(12):6961-7. PubMed ID: 14662904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naturally acquired CD8+ cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein.
    Sedegah M; Sim BK; Mason C; Nutman T; Malik A; Roberts C; Johnson A; Ochola J; Koech D; Were B
    J Immunol; 1992 Aug; 149(3):966-71. PubMed ID: 1634778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human CD4+ T cells induced by synthetic peptide malaria vaccine are comparable to cells elicited by attenuated Plasmodium falciparum sporozoites.
    Calvo-Calle JM; Oliveira GA; Nardin EH
    J Immunol; 2005 Dec; 175(11):7575-85. PubMed ID: 16301667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant vaccinia viruses for the characterization of Plasmodium falciparum-specific cytotoxic T lymphocytes: recognition of processed antigen despite limited re-stimulation efficacy.
    Aidoo M; Lalvani A; Whittle HC; Hill AV; Robson KJ
    Int Immunol; 1997 May; 9(5):731-7. PubMed ID: 9184918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of the Immunodominant CD8
    Gibbins MP; Müller K; Glover M; Liu J; Putrianti ED; Bauza K; Reyes-Sandoval A; Matuschewski K; Silvie O; Hafalla JCR
    Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32719159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses.
    Powell TJ; Tang J; Derome ME; Mitchell RA; Jacobs A; Deng Y; Palath N; Cardenas E; Boyd JG; Nardin E
    Vaccine; 2013 Apr; 31(15):1898-904. PubMed ID: 23481177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation.
    Ewer KJ; O'Hara GA; Duncan CJ; Collins KA; Sheehy SH; Reyes-Sandoval A; Goodman AL; Edwards NJ; Elias SC; Halstead FD; Longley RJ; Rowland R; Poulton ID; Draper SJ; Blagborough AM; Berrie E; Moyle S; Williams N; Siani L; Folgori A; Colloca S; Sinden RE; Lawrie AM; Cortese R; Gilbert SC; Nicosia A; Hill AV
    Nat Commun; 2013; 4():2836. PubMed ID: 24284865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference.
    Forbes EK; Biswas S; Collins KA; Gilbert SC; Hill AV; Draper SJ
    J Immunol; 2011 Oct; 187(7):3738-50. PubMed ID: 21876036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccine efficacy against malaria by the combination of porcine parvovirus-like particles and vaccinia virus vectors expressing CS of Plasmodium.
    Rodríguez D; González-Aseguinolaza G; Rodríguez JR; Vijayan A; Gherardi M; Rueda P; Casal JI; Esteban M
    PLoS One; 2012; 7(4):e34445. PubMed ID: 22529915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines.
    Espinosa DA; Vega-Rodriguez J; Flores-Garcia Y; Noe AR; Muñoz C; Coleman R; Bruck T; Haney K; Stevens A; Retallack D; Allen J; Vedvick TS; Fox CB; Reed SG; Howard RF; Salman AM; Janse CJ; Khan SM; Zavala F; Gutierrez GM
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human CD8+ T cells mediate protective immunity induced by a human malaria vaccine in human immune system mice.
    Li X; Huang J; Zhang M; Funakoshi R; Sheetij D; Spaccapelo R; Crisanti A; Nussenzweig V; Nussenzweig RS; Tsuji M
    Vaccine; 2016 Aug; 34(38):4501-4506. PubMed ID: 27502569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein.
    Wang R; Epstein J; Charoenvit Y; Baraceros FM; Rahardjo N; Gay T; Banania JG; Chattopadhyay R; de la Vega P; Richie TL; Tornieporth N; Doolan DL; Kester KE; Heppner DG; Norman J; Carucci DJ; Cohen JD; Hoffman SL
    J Immunol; 2004 May; 172(9):5561-9. PubMed ID: 15100299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation and characterization of malaria-specific human CD8(+) lymphocyte clones: effect of natural polymorphism on T cell recognition and endogenous cognate antigen presentationby liver cells.
    Bonelo A; Valmori D; Triponez F; Tiercy JM; Mentha G; Oberholzer J; Champagne P; Romero JF; Esposito F; Nebié I; Barbey C; Romero P; Herrera S; Corradin G; López JA
    Eur J Immunol; 2000 Nov; 30(11):3079-88. PubMed ID: 11093122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.
    Chuang I; Sedegah M; Cicatelli S; Spring M; Polhemus M; Tamminga C; Patterson N; Guerrero M; Bennett JW; McGrath S; Ganeshan H; Belmonte M; Farooq F; Abot E; Banania JG; Huang J; Newcomer R; Rein L; Litilit D; Richie NO; Wood C; Murphy J; Sauerwein R; Hermsen CC; McCoy AJ; Kamau E; Cummings J; Komisar J; Sutamihardja A; Shi M; Epstein JE; Maiolatesi S; Tosh D; Limbach K; Angov E; Bergmann-Leitner E; Bruder JT; Doolan DL; King CR; Carucci D; Dutta S; Soisson L; Diggs C; Hollingdale MR; Ockenhouse CF; Richie TL
    PLoS One; 2013; 8(2):e55571. PubMed ID: 23457473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conserved repetitive epitope recognized by CD4+ clones from a malaria-immunized volunteer.
    Nardin EH; Herrington DA; Davis J; Levine M; Stuber D; Takacs B; Caspers P; Barr P; Altszuler R; Clavijo P
    Science; 1989 Dec; 246(4937):1603-6. PubMed ID: 2480642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.